/
CBLL
$19.96-$0.02 (-0.10%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$758.1M
38M shares
52-week range
$10.85 – $24.33
68% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.35%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-5.04
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue | $25.9M | $45.2M | $65.4M | $89.1M |
| Cost of revenue | $4.4M | $7.1M | $8.7M | $10.8M |
| Gross profit | $21.5M | $38.2M | $56.8M | $78.3M |
| Gross margin | 82.9% | 84.4% | 86.7% | 87.9% |
| R&D | $7.2M | $9.0M | $13.6M | $19.1M |
| Operating income | −$36.0M | −$30.0M | −$39.7M | −$58.4M |
| EBITDA | −$35.1M | −$26.5M | −$37.3M | −$50.2M |
| Net income | −$37.2M | −$29.5M | −$40.5M | −$53.4M |
| Net margin | -143.4% | -65.1% | -61.8% | -60.0% |
| EPS (diluted) | -1.59 | -1.26 | -3.39 | -1.46 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $114M | $-1.71 | $-1.78–$-1.57 | 6 |
| 2027 | $146M | $-1.15 | $-1.29–$-0.90 | 6 |
| 2028 | $187M | $-0.84 | $-1.03–$-0.65 | 4 |
| 2029 | $229M | $-0.60 | $-0.61–$-0.59 | 2 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
CeriBell, Inc. Common Stock
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
www.ceribell.com- Employees
- 300
- IPO / List date
- Oct 11, 2024
- HQ
- SUNNYVALE, CA
Held by traders on TradeandTell
No one on the platform currently holds CBLL.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-12-31 | 41,900 | $1.1M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CBLL yet.
